Brief: Cohance Lifesciences Says USFDA Conducted Inspection At Hyderabad Manufacturing Facility
05/08/2026 15:29
BRIEF-Cohance Lifesciences Says USFDA Conducted Inspection At Hyderabad Manufacturing Facility Aug 5 (Reuters) - Cohance Lifesciences Ltd COHA.NS:
COHANCE LIFESCIENCES LTD - USFDA CONDUCTED INSPECTION OF CO'S MANUFACTURING FACILITY AT HYDERABAD
COHANCE LIFESCIENCES - RECEIVED A FORM FDA 483 CONTAINING FIVE OBSERVATIONS FOR HYDERABAD FACILITY
Source text: [ID:]
Further company coverage: COHA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss